EVMS Home Secondary Page Menubar
Department Information
Clinical Care
Education
Research
* About the Scientists
* Achievements
* Collaborations
* Clinical Research
* Publications
* Executive Medicine Program
Patient Information
Diabetes Center Foundation (off-site)

Strelitz Diabetes Center: The Research Institute

Neuropathy Research Abstracts

Laminin Reverses the Neurotoxicity of Sera From Patients With Neuropathy.

Gary L. Pittenger*, Nina Burcus, Aaron I. Vinik*, Norfolk, VA.

  • Sera from patients with diabetic neuropathy exert neurotoxicity on N1E-115 neuroblastoma cells (NB) by an autoimmune induction of apoptosis that correlates with sensory dysfunction. There is a down-regulation of laminin gene expression in sensory dorsal root ganglion neurons in streptozotocin diabetic rats. Since upregulation of both laminin and its b 2 subunit are associated with enhanced neurite outgrowth, we tested the possibility that laminin might reverse the neurotoxicity of patient sera. NB were cultured for 4 days in DMEM supplemented with 10% of either pooled human serum (PHS, Sigma) or patient test sera selected for their neurotoxicity. Another set of identical cultures were treated with 20m g/ml laminin. There was no signficant effect of laminin on PHS treated cultures (88,833± 76,314, mean increment ± SEM on day 4 of culture). Of 18 patients’ sera tested, neurotoxicity was reversed in 14 cultures treated with toxic sera, including sera from IDDM (663,6851 132,970,n=7), NIDDM (744,688± 29,688, n=5) or non-diabetic neuropathy (707,250± 101,829, n=6) patients (p<0.02, ANOVA). Sera that failed to reverse toxicity with 20m g/ml were tested with doses of 100 and 50 m g/ml of laminin to test whether higher doses might overcome toxicity. A dose-dependent response was detected in cultures treated with these sera, although there was not a return to the levels found in "responders." Tests with equimolar amounts of the b 1 chain of laminin showed an ability to reverse neurotoxicity in a subset of "responders," but was not able to completely mimic the effects of the whole laminin molecule.

  • These data indicate that impaired laminin gene expression might favor development of sensory neuropathy induced by serum-mediated apoptosis, correctible in vitro with exogenous laminin. Thus, laminin might be an important neurotrophic factor for the reversal of neuropathy, not just in diabetes but also in other forms of autoimmune neuropathy.

Home / Site Map / Search / About EVMS / Patient Services
Education / Research / Departments / Library

Feedback / Copyright © 1999-2008 Eastern Virginia Medical School